PeptidePedia The community reference

Contributions of HalfLifeHavel

User contributions·21 logged edits·page 1 of 1

Contributions by HalfLifeHavel, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 1,311 edits includes activity predating the current log.

  1. 19:47, 17 Jul 2026 (diff | hist) Dual incretin agonist 5,851 ±0 m state the substitution in one-letter code as well, per PP:MOS
  2. 23:57, 15 Jul 2026 (diff | hist) Enteroendocrine L cell 5,083 ±0 clarify that the incretin effect is defined by the oral–intravenous comparison
  3. 10:56, 14 Jun 2026 (diff | hist) Arcuate nucleus 5,251 ±0 add the species in which the knockout work was done
  4. 04:52, 27 Apr 2026 (diff | hist) Proglucagon 6,709 ±0 expand §Tissue-specific processing
  5. 10:22, 7 Apr 2026 (diff | hist) Talk:Albumin binding half-life extension 400 +160 /* Bound fraction figure */ new section
  6. 15:44, 30 Mar 2026 (diff | hist) Proglucagon 6,709 ±0 m typo
  7. 13:10, 22 Feb 2026 (diff | hist) Talk:Subcutaneous injection 611 +151 /* Extrapolating insulin site data */ reply
  8. 08:55, 5 Feb 2026 (diff | hist) Talk:GLP-1 receptor agonist 822 +157 /* Half-life table: are the figures comparable? */ reply
  9. 09:12, 4 Feb 2026 (diff | hist) Talk:GLP-1 receptor agonist 400 +256 /* Half-life table: are the figures comparable? */ new section
  10. 15:46, 15 Nov 2025 (diff | hist) Receptor bias 4,477 ±0 m add the reference range with the assay it was established on
  11. 14:46, 30 Sep 2025 (diff | hist) Shanghai Wibson Biotechnology 12,527 +1,119 attribute the documentation description to the purchaser reports it comes from
  12. 12:11, 14 Aug 2025 (diff | hist) Analytical method validation 5,342 ±0 correct the water-content figure — the source reports it on a dry basis
  13. 08:45, 26 Jul 2025 (diff | hist) Albumin binding half-life extension 6,021 ±0 m expand §Physical basis
  14. 06:04, 21 Jun 2025 (diff | hist) Insulin syringe 4,667 ±0 state the number of doses a vial yields at that concentration
  15. 22:34, 6 Jun 2025 (diff | hist) Incretin effect 6,953 +1,020 fix a broken wikilink
  16. 11:53, 18 May 2025 (diff | hist) Proglucagon 5,743 ±0 m the half-life given was for the intact peptide; label it
  17. 13:03, 13 Jan 2025 (diff | hist) Dipeptidyl peptidase-4 5,763 +856 the numbers in the lead disagreed with the body; body was right
  18. 08:53, 22 Oct 2024 (diff | hist) GLP-1 receptor 4,864 ±0 alphabetise the see-also list
  19. 23:41, 16 Oct 2024 (diff | hist) Beta cell function 3,162 +416 m correct the second-messenger pathway named in the lead
  20. 00:36, 14 Sep 2024 (diff | hist) Satiety signalling 2,170 ±0 m ce, tighten prose
  21. 18:56, 2 Sep 2024 (diff | hist) Glucagon-like peptide-1 5,827 +397 m move the trial material out of §Physiology into the compound articles